119 related articles for article (PubMed ID: 24098480)
41. RAGE during infectious diseases.
van Zoelen MA; Achouiti A; van der Poll T
Front Biosci (Schol Ed); 2011 Jun; 3(3):1119-32. PubMed ID: 21622260
[TBL] [Abstract][Full Text] [Related]
42. Advanced glycation end product recognition by the receptor for AGEs.
Xue J; Rai V; Singer D; Chabierski S; Xie J; Reverdatto S; Burz DS; Schmidt AM; Hoffmann R; Shekhtman A
Structure; 2011 May; 19(5):722-32. PubMed ID: 21565706
[TBL] [Abstract][Full Text] [Related]
43. Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells.
He M; Kubo H; Morimoto K; Fujino N; Suzuki T; Takahasi T; Yamada M; Yamaya M; Maekawa T; Yamamoto Y; Yamamoto H
EMBO Rep; 2011 Apr; 12(4):358-64. PubMed ID: 21399623
[TBL] [Abstract][Full Text] [Related]
44. Septic shock is associated with receptor for advanced glycation end products ligation of LPS.
Yamamoto Y; Harashima A; Saito H; Tsuneyama K; Munesue S; Motoyoshi S; Han D; Watanabe T; Asano M; Takasawa S; Okamoto H; Shimura S; Karasawa T; Yonekura H; Yamamoto H
J Immunol; 2011 Mar; 186(5):3248-57. PubMed ID: 21270403
[TBL] [Abstract][Full Text] [Related]
45. Ion mobility separation coupled with MS detects two structural states of Alzheimer's disease Aβ1-40 peptide oligomers.
Kłoniecki M; Jabłonowska A; Poznański J; Langridge J; Hughes C; Campuzano I; Giles K; Dadlez M
J Mol Biol; 2011 Mar; 407(1):110-24. PubMed ID: 21237171
[TBL] [Abstract][Full Text] [Related]
46. Hydrogen exchange mass spectrometry for studying protein structure and dynamics.
Konermann L; Pan J; Liu YH
Chem Soc Rev; 2011 Mar; 40(3):1224-34. PubMed ID: 21173980
[TBL] [Abstract][Full Text] [Related]
47. Structural basis for ligand recognition and activation of RAGE.
Koch M; Chitayat S; Dattilo BM; Schiefner A; Diez J; Chazin WJ; Fritz G
Structure; 2010 Oct; 18(10):1342-52. PubMed ID: 20947022
[TBL] [Abstract][Full Text] [Related]
48. The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding.
Park H; Adsit FG; Boyington JC
J Biol Chem; 2010 Dec; 285(52):40762-70. PubMed ID: 20943659
[TBL] [Abstract][Full Text] [Related]
49. Intertwined structured and unstructured regions of exRAGE identified by monitoring hydrogen-deuterium exchange.
Kupniewska-Kozak A; Gospodarska E; Dadlez M
J Mol Biol; 2010 Oct; 403(1):52-65. PubMed ID: 20732329
[TBL] [Abstract][Full Text] [Related]
50. Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction.
Zong H; Madden A; Ward M; Mooney MH; Elliott CT; Stitt AW
J Biol Chem; 2010 Jul; 285(30):23137-46. PubMed ID: 20504772
[TBL] [Abstract][Full Text] [Related]
51. Hydrogen exchange mass spectrometry: what is it and what can it tell us?
Marcsisin SR; Engen JR
Anal Bioanal Chem; 2010 Jun; 397(3):967-72. PubMed ID: 20195578
[TBL] [Abstract][Full Text] [Related]
52. Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8.
Krieger E; Joo K; Lee J; Lee J; Raman S; Thompson J; Tyka M; Baker D; Karplus K
Proteins; 2009; 77 Suppl 9(Suppl 9):114-22. PubMed ID: 19768677
[TBL] [Abstract][Full Text] [Related]
53. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications.
Bierhaus A; Nawroth PP
Diabetologia; 2009 Nov; 52(11):2251-63. PubMed ID: 19636529
[TBL] [Abstract][Full Text] [Related]
54. RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts.
Ramasamy R; Yan SF; Schmidt AM
J Leukoc Biol; 2009 Sep; 86(3):505-12. PubMed ID: 19477910
[TBL] [Abstract][Full Text] [Related]
55. Binding of S100 proteins to RAGE: an update.
Leclerc E; Fritz G; Vetter SW; Heizmann CW
Biochim Biophys Acta; 2009 Jun; 1793(6):993-1007. PubMed ID: 19121341
[TBL] [Abstract][Full Text] [Related]
56. Solution structure of the variable-type domain of the receptor for advanced glycation end products: new insight into AGE-RAGE interaction.
Matsumoto S; Yoshida T; Murata H; Harada S; Fujita N; Nakamura S; Yamamoto Y; Watanabe T; Yonekura H; Yamamoto H; Ohkubo T; Kobayashi Y
Biochemistry; 2008 Nov; 47(47):12299-311. PubMed ID: 19032093
[TBL] [Abstract][Full Text] [Related]
57. The HMGB1 receptor RAGE mediates ischemic brain damage.
Muhammad S; Barakat W; Stoyanov S; Murikinati S; Yang H; Tracey KJ; Bendszus M; Rossetti G; Nawroth PP; Bierhaus A; Schwaninger M
J Neurosci; 2008 Nov; 28(46):12023-12031. PubMed ID: 19005067
[TBL] [Abstract][Full Text] [Related]
58. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42.
Hudson BI; Kalea AZ; Del Mar Arriero M; Harja E; Boulanger E; D'Agati V; Schmidt AM
J Biol Chem; 2008 Dec; 283(49):34457-68. PubMed ID: 18922799
[TBL] [Abstract][Full Text] [Related]
59. Internalization of the receptor for advanced glycation end products (RAGE) is required to mediate intracellular responses.
Sevillano N; Girón MD; Salido M; Vargas AM; Vilches J; Salto R
J Biochem; 2009 Jan; 145(1):21-30. PubMed ID: 18849572
[TBL] [Abstract][Full Text] [Related]
60. Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE).
Xie J; Reverdatto S; Frolov A; Hoffmann R; Burz DS; Shekhtman A
J Biol Chem; 2008 Oct; 283(40):27255-69. PubMed ID: 18667420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
